Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Bone physiology
-
1. Pathways regulating bone resorption
- Prof. Tim Arnett
-
2. Pathways regulating bone formation
- Dr. Michaela Kneissel
-
3. The osteocyte
- Prof. Lynda F. Bonewald
- Osteoporosis
-
4. Epidemiology of osteoporosis
- Prof. Cyrus Cooper
-
5. Pharmacotherapy of osteoporosis 1
- Dr. Michael McClung
-
6. Pharmacotherapy of osteoporosis 2
- Dr. Michael McClung
-
7. Current concepts for the management of patients with osteoporosis
- Dr. Michael Lewiecki
-
8. Combination and sequential therapy for the treatment of osteoporosis
- Prof. Felicia Cosman
-
9. Osteoporosis in men
- Prof. Peter R. Ebeling
-
10. Glucocorticoids, inflammation and bone loss
- Prof. Christian Roux
-
11. Atypical femoral fractures
- Dr. Angela Cheung
-
12. How long to treat osteoporosis
- Prof. Robert A. Adler
-
13. Osteoporosis: calcium and vitamin D
- Prof. Bo Abrahamsen
- Archived Lectures *These may not cover the latest advances in the field
-
14. New and emerging treatments for osteoporosis
- Dr. Michael Lewiecki
-
15. Osteoporosis: how long to treat?
- Prof. Robert A. Adler
Printable Handouts
Navigable Slide Index
- Introduction
- Disclosures
- UVB and fracture risk
- Vitamin D supplementation and BMD
- Effect if vitamin D on falls
- Challenges
- More challenges
- Calcium and vitamin D in osteoporosis
- Hip fracture risk and serum 25-OHD in Norway
- Comparison with observational cohort studies
- Annual vitamin D – falls and fractures
- Annual IM vitamin D on falls and fractures 2007
- Hypotheses re intermittent high doses
- Vitamin D bolus and bone turnover
- VDR knockout model
- DIPART fracture study
- NEJM 2012 – vitamin D dose and fractures
- Bischoff-Ferrari study (methods and results)
- Bischoff-Ferrari study (results by quartile)
- Bischoff-Ferrari study (baseline & fracture risk)
- WHI study
- CaD as an adjunct to osteoporosis drugs
- Calcium and vitamin D in osteoporosis
- Safety - heart disease
- Observational studies
- Swedish mammography cohort
- US NHANES health survey (cardiovascular death)
- Milk and all-cause mortality (methods and results)
- Milk and all-cause mortality (more results)
- Intervention studies
- Calcium alone - Bolland 2010 analysis of RCTs
- Bolland 2010 analysis (sources and outcome)
- Bolland 2010 analysis (prespecified subgroup)
- Bolland 2010 analysis (criticism)
- Bolland 2011 re-analysis of the WHI study
- Limitations to Bolland WHI analysis
- Safety - renal stones
- Renal stones in WHI (ITT analysis)
- Renal stones in WHI (EFSA comments)
- Key messages
Topics Covered
- Vitamin D: Bone density, falls and fractures
- Challenges in design and interpretation of vitamin D studies
- Associations between serum level of vitamin D and fracture risk
- Intervention studies: with vitamin D, with calcium and vitamin D
- Calcium and vitamin D as an adjunct to osteoporosis drugs
- Safety: Heart disease, Death, Renal stones
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Abrahamsen, B. (2015, January 19). Osteoporosis: calcium and vitamin D [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 31, 2024, from https://doi.org/10.69645/OECD6871.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Bo Abrahamsen, Institution: Research contracts Novartis (current), Amgen (past), Merck (past).
A selection of talks on Cardiovascular & Metabolic
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my
name is Bo Abrahamsen.
I'm a professor at the
University of Southern Denmark
and the Research Center
for Aging and Osteoporosis
in Glostrup Hospital, Copenhagen.
My talk today is Osteoporosis
Calcium and Vitamin D.
And I will try to talk
about some studies
that I think may be familiar to you.
So it may be you'll find you'll
have to go back and perhaps read
the paper in question to fully
understand what I'm getting at,
so maybe one or two places.
I'm not giving a
lot of introduction.
But rather, assume that you may
have already read the papers.
Because they've been really widely
discussed in the past years.
0:34
These are my disclosures.
I'm not speaking on behalf of any
of the organizations listed here
at all.
0:42
As you probably know,
there's difference
in fracture risk in
different parts of the world.
And there's a little bit of a
tendency for fractures to be rarer
the nearer you get to the Equator.
So that would of course drive the
hypothesis that perhaps the lack
of vitamin D in the Northern
and Southern Hemisphere
as you get away from
the Equator would
be one of the reasons
there are more fractures.
So if you look at the
right hand of the slide,
you'll see rates from
the International
Osteoporosis Foundation.
And as you can see, Argentina,
Iceland, and Norway all
have fairly high fracture
rates, whereas Central Africa
and the northern part of Latin
America all have low rates.
And these are the very
sun-rich areas of the world.
But you can also see fairly
high rates of fractures
in the Middle East and in the
European and Asian part of Turkey.
1:38
It's been difficult to show any
convincing effects of vitamin
D supplementation in the general
population on bone mineral density.
As you know, bone mineral
density is an important risk
factor for fracture.
It's not the only one, but
it's a really important one.
And there was a really nice
meta-analysis in The Lancet
this year looking at a number
of intervention trials.
And then on the left part of the
chart showing the mean difference
in numbers on BMD
with supplementation
this is percent change
in lumbar spine BMD.
And as you can see, the
average increase is zero.
If you look at the right
hand, you have the chart,
you have the femoral
neck BMD where there
is a small significant
increase, but of less than 1%.
And you may know that a
standard deviation of BMD
is about 10% or 11%.
And that's the order
of a change that's
needed to reduce
fracture risk by half.
So these are quite small and quite,
perhaps, inconsistent findings.
The authors conclude that this
systematic review provides
very little evidence
of an overall benefit
of vitamin D supplementation
on bone density.
They also conclude that
there's a small BMD
benefit potentially
at the femoral neck.
But they also find signs of
significant publication bias
as assessed by funnel plots.
And you also notice
significant heterogeneity
between studies statistically.
So there's no clear BMD effect in
the general public of vitamin D
supplementation, though
of course as clinicians,
we know that in an individual
patient who is vitamin D deficient,
the response in BMD can be huge.